• We are a biopharmaceutical company, specialized in allergic, diseases that offers physicians a wide range of diagnosis and treatment products
    Read More
  • Allergic disease may result in rhinitis, rhinoconjunctivitis, asthma and/or urticaria. It is necessary to carry out a proper study for
    Read More
  • A few years ago, Diater, which has a very well established presence in Spain, started an ambitious internationalisation plan to
    Read More
  • Diater is working on different lines of R&D in the field of diagnosis, both in vivo and in vitro, and
    Read More
  • Diater’s Research and Development department (R&D) has advanced techniques and the best equipment in the areas of chemical synthesis, proteomics
    Read More
  • Our strategic objectives include seeking partners with which to build strategic alliances that allow us to strengthen and diversify our
    Read More


We hereby inform you that the personal data submitted by you shall be processed by GRUPO FERRER INTERNACIONAL S.A., whose registered address is at Av. Diagonal 549, 5ª planta, 08029, Barcelona (Spain), so that it may maintain and handle its relations with you, as well as to respond to any queries you may submit to us. 

Your personal data shall be stored for 1 year since you submitted your first query.

All personal data processed is based on you having given your consent to do so. You are reminded that you may withdraw your consent at any time.

You may exercise your rights of access, rectification, erasure, restriction of processing, portability of data, as well as to submit any queries or suggestions in respect of the processing of personal data by writing to the Data Protection Officer using any of the following means, along with a copy of your ID document or other means of identification:

(i) By email to

(ii) By post addressed to GRUPO FERRER INTERNACIONAL S.A. Av. Diagonal nº 549, 5ª planta, 08029, Barcelona.

You are entitled to submit complaints to the Spanish Data Protection Agency (AEPD), the competent authority on data protection matters by writing a letter to its central offices.

Link to the privacy policy

security image


914 96 60 13
This email address is being protected from spambots. You need JavaScript enabled to view it.
Share This
Follow Us